|
Volumn 36, Issue 7, 2004, Pages 2082-2083
|
Primary immunosuppression with tacrolimus in kidney transplantation: Three-year follow-up in a single center
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
TACROLIMUS;
ALOPECIA;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DATA ANALYSIS;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG SAFETY;
FOLLOW UP;
GINGIVA HYPERPLASIA;
GRAFT SURVIVAL;
HAND;
HEADACHE;
HIRSUTISM;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERKALEMIA;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
NEPHROTOXICITY;
NEUROTOXICITY;
PHASE 4 CLINICAL TRIAL;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SIDE EFFECT;
STATISTICAL SIGNIFICANCE;
SURVIVAL RATE;
TREMOR;
VIRUS INFECTION;
CYCLOSPORINE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TACROLIMUS;
|
EID: 7044227653
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.08.006 Document Type: Conference Paper |
Times cited : (13)
|
References (4)
|